Cardioplegia Solution recalled due to lack of sterility assurance
Central Admixture Pharmacy Services is recalling its Cardioplegia Solution due to lack of assurance of sterility. An FDA inspection determined that the sterility of these products intended for cardiac surgery could not be assured.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of a sterile injectable product where the manufacturer cannot assure sterility. Per the severity rubric, a risk-of-harm product for use in cardiac surgery where injury has not yet been reported receives a score of 3 (High).
Plain-English summary
Central Admixture Pharmacy Services, Inc. is recalling its Cardioplegia Solution, Warm Induction 4:1 High Potassium (40 mEq) in 500 mL bags. The recall affects 215 bags distributed nationwide in the United States, including lot numbers 37-893802 (expires 04/28/2023), 37-894943 (expires 05/01/2023), 37-896487 (expires 05/07/2023), 37-898248 (expires 05/14/2023), and 37-899171 (expires 05/19/2023).
The FDA inspected the manufacturer and called into question the sterility of these products, which are intended to be sterile. The manufacturer is recalling the product due to a lack of assurance of sterility.
Consumers and facilities that have received these products should refer to the product's labeling for further information regarding the recall.
The recalled product
- Product
- Cardioplegia Solution, Warm Induction 4:1 High Potassium (40 mEq) packaged in 500 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0002-1.
- Manufacturer
- Central Admixture Pharmacy Services, Inc.
- Category
- Drug — Sterile Injectable
- Hazard
- lack-of-sterility-assurance
- contamination-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (10)
- Lot # 37-893802
- Exp 04/28/2023
- 37-894943
- Exp 05/01/2023
- 37-896487
- Exp 05/07/2023
- 37-898248
- Exp 05/14/2023
- 37-899171
- Exp 05/19/2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27